TY - JOUR
T1 - Silicone oil in the repair of pediatric complex retinal detachments
T2 - A prospective, observational, multicenter study
AU - Scott, Ingrid U.
AU - Flynn, Harry W.
AU - Azen, Stanley P.
AU - Lai, Mei Ying
AU - Schwartz, Steven
AU - Trese, Michael T.
N1 - Funding Information:
Supported in part by a grant from Richard-James, Inc., Peabody, Massachusetts (HWF, Jr., IUS); a Heed Ophthalmic Foundation Fellowship, Cleveland, Ohio (IUS); a Ronald G. Michels Foundation Fellowship, Philadelphia, Pennsylvania (IUS); a grant from Alcon, Inc., Fort Worth, Texas (SPA, MYL); and a Core Grant for Vision Research NIH NEI-EY-03040 (SPA, MYL). The funding sources did not have a role in deciding whether the study would be submitted for publication.
PY - 1999/7/1
Y1 - 1999/7/1
N2 - Objective: To report anatomic and visual acuity outcomes, as well as complications, after using 1000-centistoke silicone oil as a retinal tamponade for the treatment of complex retinal detachments in a pediatric population. Design: A prospective, observational, multicenter study. Participants: The study cohort consisted of 205 patients 16 years of age or younger (211 eyes) treated at community and university-based ophthalmology clinics for complex retinal detachments associated with trauma, proliferative vitreoretinopathy (PVR), giant retinal tear (GRT), or retinopathy of prematurity (ROP). Intervention: Vitrectomy surgery for complex retinal detachment with 1000-centistoke silicone oil as the retinal tamponade. Main Outcome Measures: Anatomic outcomes include complete retinal attachment and macular attachment. Visual acuity outcomes include ambulatory vision (≥4/200) and preservation of preoperative visual acuity. Complications include rates of secondary intraocular pressure (IOP) elevation (≥30 mmHg), hypotony (≤5 mmHg), corneal opacification (including band keratopathy, corneal edema, and corneal abrasions), oil emulsification, and cataract. All outcome measures were assessed 6, 12, and 24 months after surgery and at last examination. Results: At the 6-month examination, the retina was completely attached in 43 (57%) of 76 eyes in the trauma group, 24 (63%) of 38 PVR eyes, 23 (68%) of 34 GRT eyes, and 6 (33%) of 18 ROP eyes. The macula was attached in 60 (79%), 33 (87%), 26 (76%), and 8 (44%) eyes, respectively. Ambulatory vision was achieved in 19 (25%) eyes in the trauma group, 18 (47%) PVR eyes, 19 (56%) GRT eyes, and 4 (22%) ROP eyes. Visual acuity was preserved in 53 (70%), 26 (68%), 28 (82%), and 9 (50%) eyes, respectively. The corresponding rates of complications for traumatic, PVR, GRT, and ROP eyes were: elevated IOP - 3 (4%) of 76, 1 (3%) of 38, 1 (3%) of 34, and 0 (0%) of 18; hypotony - 9 (12%), 3 (8%), 2 (6%), and 2 (11%); corneal opacity - 25 (33%), 8 (21%), 15 (44%), and 5 (28%); emulsification - 4 (5%), 1 (3%), 3 (9%), and 1 (6%); and cataract in phakic eyes - 1 (33%) of 3, 2 (67%) of 3, 2 (50%) of 4, and 1 (33%) of 3. Conclusions: Retinal reattachment and preserved visual acuity were achieved in the majority of eyes using vitrectomy and silicone oil retinal tamponade. Complete retinal and macular attachment was achieved less frequently in ROP eyes than in eyes in the other diagnostic groups. Use of 1000-centistoke silicone oil can be considered in the management of pediatric complex retinal detachments associated with multiple etiologies.
AB - Objective: To report anatomic and visual acuity outcomes, as well as complications, after using 1000-centistoke silicone oil as a retinal tamponade for the treatment of complex retinal detachments in a pediatric population. Design: A prospective, observational, multicenter study. Participants: The study cohort consisted of 205 patients 16 years of age or younger (211 eyes) treated at community and university-based ophthalmology clinics for complex retinal detachments associated with trauma, proliferative vitreoretinopathy (PVR), giant retinal tear (GRT), or retinopathy of prematurity (ROP). Intervention: Vitrectomy surgery for complex retinal detachment with 1000-centistoke silicone oil as the retinal tamponade. Main Outcome Measures: Anatomic outcomes include complete retinal attachment and macular attachment. Visual acuity outcomes include ambulatory vision (≥4/200) and preservation of preoperative visual acuity. Complications include rates of secondary intraocular pressure (IOP) elevation (≥30 mmHg), hypotony (≤5 mmHg), corneal opacification (including band keratopathy, corneal edema, and corneal abrasions), oil emulsification, and cataract. All outcome measures were assessed 6, 12, and 24 months after surgery and at last examination. Results: At the 6-month examination, the retina was completely attached in 43 (57%) of 76 eyes in the trauma group, 24 (63%) of 38 PVR eyes, 23 (68%) of 34 GRT eyes, and 6 (33%) of 18 ROP eyes. The macula was attached in 60 (79%), 33 (87%), 26 (76%), and 8 (44%) eyes, respectively. Ambulatory vision was achieved in 19 (25%) eyes in the trauma group, 18 (47%) PVR eyes, 19 (56%) GRT eyes, and 4 (22%) ROP eyes. Visual acuity was preserved in 53 (70%), 26 (68%), 28 (82%), and 9 (50%) eyes, respectively. The corresponding rates of complications for traumatic, PVR, GRT, and ROP eyes were: elevated IOP - 3 (4%) of 76, 1 (3%) of 38, 1 (3%) of 34, and 0 (0%) of 18; hypotony - 9 (12%), 3 (8%), 2 (6%), and 2 (11%); corneal opacity - 25 (33%), 8 (21%), 15 (44%), and 5 (28%); emulsification - 4 (5%), 1 (3%), 3 (9%), and 1 (6%); and cataract in phakic eyes - 1 (33%) of 3, 2 (67%) of 3, 2 (50%) of 4, and 1 (33%) of 3. Conclusions: Retinal reattachment and preserved visual acuity were achieved in the majority of eyes using vitrectomy and silicone oil retinal tamponade. Complete retinal and macular attachment was achieved less frequently in ROP eyes than in eyes in the other diagnostic groups. Use of 1000-centistoke silicone oil can be considered in the management of pediatric complex retinal detachments associated with multiple etiologies.
UR - http://www.scopus.com/inward/record.url?scp=0033509862&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033509862&partnerID=8YFLogxK
U2 - 10.1016/S0161-6420(99)00731-9
DO - 10.1016/S0161-6420(99)00731-9
M3 - Article
C2 - 10406629
AN - SCOPUS:0033509862
SN - 0161-6420
VL - 106
SP - 1399
EP - 1408
JO - Ophthalmology
JF - Ophthalmology
IS - 7
ER -